NAD(P)H:quinone oxidoreductase 1 (NQO1) regulates the stability of the tumor suppressor WT p53. NQO1 binds and stabilizes WT p53, whereas NQO1 inhibitors including dicoumarol and various other coumarins and flavones induce ubiquitin-independent proteasomal p53 degradation and thus inhibit p53-induced apoptosis. Here, we show that curcumin, a natural phenolic compound found in the spice turmeric, induced ubiquitin-independent degradation of WT p53 and inhibited p53-induced apoptosis in normal thymocytes and myeloid leukemic cells. Like dicoumarol, curcumin inhibited the activity of recombinant NQO1 in vitro, inhibited the activity of endogenous cellular NQO1 in vivo, and dissociated NQO1-WT p53 complexes. Neither dicoumarol nor curcumin dissociated the complexes of NQO1 and the human cancer hot-spot p53 R273H mutant and therefore did not induce degradation of this mutant. NQO1 knockdown by small-interfering RNA induced degradation of both WT p53 and the p53 R273H mutant. The results indicate that curcumin induces p53 degradation and inhibits p53-induced apoptosis by an NQO1-dependent pathway.NQO1-dependent pathway ͉ disruption of NQO1-p53 binding ͉ cancer hot-spot p53 mutant ͉ p53-induced apoptosis W ild-type p53 is a labile tumor suppressor protein whose cellular level is mainly regulated by its rate of proteasomal degradation (reviewed in ref. 1). WT p53 protein can induce growth arrest (1-4) or apoptosis (5-8) and can thus prevent accumulation of DNA-damaged cells that could lead to the development of cancer (reviewed in refs. 1, 9, and 10). This tumor-suppressing activity of WT p53 is abolished by mutations in the p53 gene that occur in Ͼ50% of human cancers (1,11,12), and the mutant proteins often accumulate in the cancer cells (13). Degradation of p53 is mediated by two alternative pathways, ubiquitin-independent (14, 15) or ubiquitin-dependent. Ubiquitin-dependent degradation of p53 is mediated by different ubiquitin E3 ligases, including Mdm2 (16,17), Pirh2 (18), and Cop1 (19), that bind and ubiquitinate p53, targeting it to degradation via the 26S proteasome. The ubiquitin-independent pathway is regulated by NAD(P)H:quinone oxidoreductase 1 (NQO1) (14,15,20,21) and is mediated via the 20S proteasome (22). We have shown that NQO1 stabilizes p53, so that NQO1 overexpression increases p53 levels (20, 21), whereas NQO1 knockdown by small interfering RNA (siRNA) decreases the level of p53 (14). NQO1 binds to p53 (23, 24) and dicoumarol, an inhibitor of NQO1 activity that competes with NAD(P)H for binding to NQO1, disrupts NQO1-p53 binding (23), and induces ubiquitin-independent proteasomal degradation of p53 (14,15,20,21,23). Various other coumarins and flavones that also compete with NAD(P)H for binding to NQO1 also induce ubiquitin-independent p53 degradation (23). However, unlike WT p53 and some p53 mutants, the most frequent hot-spot human cancer p53 mutants (11, 12) were resistant to dicoumarolinduced degradation by increased binding to NQO1 (23).Curcumin, a natural phenolic compound found in the spice ...